patients with chronic lymphocytic leukemia , cutaneous t-cell lymphoma , or t-cell lymphoma have received 24-hr infusions of 3 to 500 mg t101 in therapeutic trials .
C0079773
cutaneous t-cell
C0079772
t-cell lymphoma